45.78
Schlusskurs vom Vortag:
$45.71
Offen:
$44.01
24-Stunden-Volumen:
102.05K
Relative Volume:
0.50
Marktkapitalisierung:
$429.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-4.5173
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
-6.50%
1M Leistung:
+48.24%
6M Leistung:
+255.14%
1J Leistung:
+16.18%
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
KRRO
Korro Bio Inc
|
45.78 | 403.53M | 0 | -81.17M | -82.84M | -10.13 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
2024-08-14 | Eingeleitet | William Blair | Outperform |
2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-10-28 | Eingeleitet | Cowen | Outperform |
2019-10-28 | Eingeleitet | Goldman | Buy |
2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Short interest data insights for Korro Bio Inc.July 2025 Setups & Weekly Breakout Stock Alerts - newser.com
Using Ichimoku Cloud for Korro Bio Inc. technicals2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Analyzing recovery setups for Korro Bio Inc. investors2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Using Python tools to backtest Korro Bio Inc. strategies2025 Top Gainers & Fast Moving Stock Trade Plans - newser.com
Tools to assess Korro Bio Inc.’s risk profileWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Is Korro Bio Inc. stock positioned for long term growthAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
Risk vs reward if holding onto Korro Bio Inc.Earnings Summary Report & AI Driven Stock Movement Reports - newser.com
Using economic indicators to assess Korro Bio Inc. potential2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Live market analysis of Korro Bio Inc.July 2025 Setups & Detailed Earnings Play Alerts - newser.com
Key metrics from Korro Bio Inc.’s quarterly dataJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Has Korro Bio Inc. formed a bullish divergence2025 Earnings Impact & Community Verified Swing Trade Signals - newser.com
Korro Bio CFO Vineet Agarwal Resigns, Interim Appointed - The Globe and Mail
Is a relief rally coming for Korro Bio Inc. holdersEarnings Growth Summary & Short-Term High Return Strategies - newser.com
Korro Bio, Inc. Announces Chief Financial Officer Changes, Effective October 17, 2025 - MarketScreener
Korro Bio CFO Vineet Agarwal to step down, CEO Ram Aiyar named interim CFO - Investing.com Canada
Korro BioVineet Agarwal announces intention to resign from his position of CFO - MarketScreener
What analysts say about Korro Bio Inc stockEarnings Growth Patterns & Free Double Digit Growth Tips - earlytimes.in
What drives Korro Bio Inc stock priceValue Traps to Avoid & Free High Yield Investment Strategies - earlytimes.in
Chart based analysis of Korro Bio Inc. trends2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Is Korro Bio Inc. stock reversal real or fake2025 Year in Review & Momentum Based Trading Ideas - newser.com
Korro Bio Inc. stock prediction for this weekWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com
When is the best time to exit Korro Bio Inc.Day Trade & AI Forecasted Entry/Exit Points - newser.com
Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates - 富途牛牛
Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $180 - 富途牛牛
Applying sector rotation models to Korro Bio Inc.Market Growth Report & Safe Capital Growth Tips - newser.com
How to build a custom watchlist for Korro Bio Inc.2025 Investor Takeaways & Community Consensus Picks - newser.com
Korro Bio Inc. stock retracement – recovery analysisWeekly Trade Report & Community Shared Stock Ideas - newser.com
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Korro Bio Inc-Aktie (KRRO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):